MTB vs TSHA · P/E 12, rev $1.66B vs $640.7M cap
M&T Bank Corporation (MTB) versus Taysha Gene Therapies Inc (TSHA) — a side-by-side from cached financials, not a winner call.
M&T Bank Corporation (MTB) is a banks - regional company listed on US.
Taysha Gene Therapies Inc (TSHA) is a biotechnology company listed on US.
Latest reported MTB revenue for 2025-12-31 was $1.66B. Net income was $2.85B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. MTB currently screens at market cap $30.99B and trailing P/E 11.9.
Latest reported TSHA revenue for 2026-06-30 was $0. Net income was -$89.0M. TSHA currently screens at market cap $640.7M.
MTB currently screens at market cap $30.99B and trailing P/E 11.9. TSHA currently screens at market cap $640.7M.
Not investment advice. Open the MTB and TSHA stock pages for the full models.
Not investment advice.